Quote | Absci Corporation (NASDAQ:ABSI)
Last: | $3.18 |
---|---|
Change Percent: | -14.14% |
Open: | $3.39 |
Close: | $3.18 |
High: | $3.5499 |
Low: | $3.13 |
Volume: | 1,327,128 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
News | Absci Corporation (NASDAQ:ABSI)
VANCOUVER, Wash. and NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced that on July 1, 2024, the company granted a non-statutory stock option to purchase an aggregate of 613,000 shares of its common stoc...
2024-07-03 10:51:31 ET More on Absci Absci: 'AI' Tag Keeping Company Afloat While Searching For Right Formula Absci Corporation (ABSI) Q1 2024 Earnings Call Transcript Seeking Alpha’s Quant Rating on Absci Historical earnings data for Absci Fin...
Message Board Posts | Absci Corporation (NASDAQ:ABSI)
Subject | By | Source | When |
---|---|---|---|
Down almost 10% today wtf | Bill Harford | investorshub | 02/10/2023 9:58:02 PM |
Absci Reports Second Quarter 2022 Financial Results and | subslover | investorshub | 08/11/2022 4:55:23 PM |
A very poorly rated analyst, but FWIW: | cheynew | investorshub | 03/23/2022 11:48:06 AM |
Absci Develops Groundbreaking Machine Learning Models for In-Silico | cheynew | investorshub | 03/22/2022 10:11:30 PM |
Absci Reports Full Year 2021 Financial and Operating Results | cheynew | investorshub | 03/22/2022 10:09:39 PM |
News, Short Squeeze, Breakout and More Instantly...
VANCOUVER, Wash. and NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced that on July 1, 2024, the company granted a non-statutory stock option to purchase an aggregate of 613,000 shares of its common stoc...
VANCOUVER, Wash. and NEW YORK, June 12, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the upcoming Morgan Stanley 3 rd Annual Life Sciences AI Summit on June 26-27 in New York, ...
VANCOUVER, Wash. and NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the upcoming Goldman Sachs 45 th Annual Global Healthcare Conference in Miami, FL. Absci...